Frontiers in Cardiovascular Medicine · Nov 16, 2026

Study Protocol: Effect of Mobile Health-Supported Integrated Lifestyle Intervention on Blood Pressure and Metabolic Parameters in Xinjiang Residents at Risk of Cardio-Cerebrovascular Diseases

By Meidina Yeerken, Bizhong Che, Qilong Guo et al.

Background This study will evaluate the effect of a mobile health (mHealth)-supported integrated lifestyle intervention on blood pressure and other metabolic parameters in residents with cardio-cerebrovascular risk factors. Methods/Design The Mobile health-supported Integrated Lifestyle Intervention for Cardio-CerebroVascular risk factors (MILIV) study is a single-center, 1:1 parallel-group, assessor-blinded randomized controlled trial. We will enroll 672 community-dwelling residents aged 45–75 years from Urumqi, China, with at least one cardio-cerebrovascular risk factor (hypertension, diabetes, dyslipidemia, or overweight/obesity). Participants will be randomly assigned to either the enhanced health management group or the basic health management group. Both groups will use a WeChat Service Account ("Jiangxin Health"), receive a smart wristband, and be invited to monthly standardized health education lectures. The enhanced group will receive the full-featured version, which includes personalized intelligent alerts for excessive caloric intake or insufficient physical activity, whereas the basic group will use a version with core features only. The primary outcome is the change in blood pressure from baseline to 3 months. The secondary outcomes include a range of other metabolic parameters and behavioral data. Conclusion The MILIV study will provide empirical evidence on the effectiveness and feasibility of an mHealth-supported lifestyle intervention for improving metabolic control among adults at risk of cardio-cerebrovascular diseases (CCVDs) in a community setting.

The paperJournal siteInterventions

AgingResearch.News